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ABSTRACT 
 
 Epigenetic modifications affect the genome without directly affecting the 
genetic code within the DNA.  There are many different types of these 
modifications and they can last for just a few cell replications or for many 
generations of cells.  Many of them involve covalent modifications of histone 
proteins, affecting the packing of the chromatin and therefore regulating the 
transcription and expression of different genes.  One epigenetic modification that 
has been considered more permanent is the methylation of the 5’ carbon on 
cytosine.  DNA methylation is performed and maintained by different DNA 
methyltransferase (DNMT) enzymes.  Recently, it has been discovered that this 
methylation is not permanent, as once thought, but rather it is reversible.   
 5mC can be hydroxymethylated by the ten-eleven translocase (TET) 
family of enzymes.  They convert 5mC into 5-hydroxymethylcytsoine (5hmC), 5-
carboxylcytosine (5caC), 5-formylcytosine (5fC).  These changes to the 
epigenome remove the effects of 5mC, changing gene transcription and 
expression levels.  It is yet to be determined how these modified cytosines are 
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recycled into an unmodified cytosine within the DNA.  There are many proposed 
mechanisms, and they all seem to involve the TET family proteins and their 
product, 5hmC. 
 One aim of this research was to isolate and purify an uncharacterized 
protein, KIAA1310, which has been found associated with the TET protein 
complex.  This protein, also known as KANSL or NSL3, has been seen 
associated with a histone acetyl transferase called MOF that is a part of the Non-
Specific Lethal (NSL) complex in both drosophila and humans.  It is not clear 
what role KIAA1310 is playing in either MOF or the TET complex it was found 
associated with.  Our aim was to isolate, purify and concentrate this protein so 
that it could undergo proteomic MS/MS analysis. 
 A stable S-HeLA cell line expressing this protein had been previously 
established, so these cells were grown in suspension culture and then harvested.  
A tandem affinity purification (TAP) assay was performed in order to isolate 
KIAA1310 from the cells.  The TAP product was then concentrated using 
trichloroacetic acid (TCA) before being subjected to MS/MS analysis by the 
epigenetic laboratory at the Fudan University in Shanghai, China.  The results 
show a large variety of proteins associated with KIAA1310, many of which are 
transcription factors or proteins involved in metabolic pathways.   
 A second aim of this research was to look at the relationship between 
5hmC and type 2 diabetes mellitus.  It has been seen that TET proteins may 
associate with a protein called O-linked N-acetylglucosamine (OGlcNAc) 
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transferase (OGT).  This protein is responsible for glycosylating serine and 
threonine residues, especially on histone proteins.  Increased OGT levels have 
been linked to increased insulin resistance, and therefore to increased incidence 
of type 2 diabetes mellitus.  This correlation, combined with the observation of a 
TET-OGT complex, led to the question of whether TET proteins are connected to 
diabetic status. 
 In order to study this possible connection between TET proteins and 
diabetes, patient DNA samples were studied for the relative quantities of 5hmC.  
An anti-5hmC dot blot was used in order to compare 5hmC levels among DNA 
samples from diabetic and control patients.  Upon analysis of this data, it was 
determined that diabetic patients have a lower quantity of 5hmC in their DNA 
than the control patients.  It was also seen that lower 5hmC levels correspond to 
higher HbA1c levels, a measure of blood glucose and therefore a determinant of 
how controlled a patient’s diabetes is.  These results suggest that the TET family 
proteins and their product, 5hmC, may in fact be connected to type 2 diabetes 
mellitus.      
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 1 
INTRODUCTION 
  
In a multicellular organism, all of the cells contain the same set of genetic 
information, the genome.  However, different tissues throughout an organism are 
distinct from one another because they express different genes and produce 
different proteins.  There are a multitude of epigenetic modifications that occur 
throughout development and cell differentiation in order to allow these tissues to 
develop uniquely.  That is, every cell has the same DNA but different cell types 
transcribe and express different genes within the genome based at least in part 
on epigenetic factors and modifications.  
 Epigenetic modifications are changes that affect the genome, and 
therefore affect gene expression, without changing the actual DNA sequence 
(Rosenfeld, 2010).  Epigenetic modifications may be easily reversible or may be 
more constant, depending on the intended effect.  Genes that are involved with 
development have variable expression and therefore use short-term epigenetic 
modifications that are flexible, like histone modifications.  Some epigenetic 
modifications are much more stable, and they are seen in genes involved with 
imprinting and long-term gene silencing (Wu and Zhang, 2010).  Modifications of 
this type generally involve the DNA itself, so the epigenetic modification will be 
passed down through many cell divisions. 
 One type of epigenetic modification is the covalent alteration of histone 
proteins.  DNA is packaged in a cell in the form of chromatin, where the DNA is 
wound around a histone core made up of eight histone proteins.  The extent of 
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packing of the DNA in the chromatin affects the ability of transcription to occur 
and therefore affects gene expression levels.  If the chromatin is in a euchromatic 
state, where it is more “open” or loosely packed, it is easier for transcription 
machinery to gain access to the DNA and therefore gene expression levels will 
be high.  However, if the chromatin is in a heterochromatic state where the DNA 
is wound more tightly around the histone, it will be more difficult for transcription 
to take place, causing repression of gene expression (REF – BIOCHEM TEXT 
BOOK). 
Many different covalent post-translational modifications, including but not 
limited to acetylation, phosphorylation, methylation, ubiquitylation, sumoylation 
and glycosylation, can occur on histones to provide the epigenetic blueprint for a 
cell (Inbar-Feigenberg et al, 2013).  Many different enzymes exist that can 
produce these histone modifications, and it has been shown that multiple 
different post-translational modifications can occur simultaneously on a histone 
protein in order to affect gene transcription by determining whether the chromatin 
is in a euchromatic or heterochromatic state (Gardner et al, 2011).  Different 
modifications of these histones will also affect the recruitment of different proteins 
to the DNA, having an impact on gene transcription (Kubiura et al, 2012).  These 
histone modifications are considered short-term epigenetic modifications 
because they may only survive through a few rounds of cell divisions before 
being reversed (Wu and Zhang, 2010).   
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DNA METHYLATION 
Another very important epigenetic modification that takes place is the 
methylation of the DNA itself.  Methylation is generally seen at the 5-position of 
the pyrimidine base cytosine, creating 5-methylcytosine or 5mC (Tan and Shi, 
2012).  In mammalian cells, this methylation occurs in regions heavily populated 
by cytosine followed by guanine, also called CpG dinucleotides, although this is 
not the case in pluripotent stem cells (Guo et al, 2011).  Methylation of the DNA 
in promoter regions of somatic cells is related to gene expression, with 5mC 
disrupting binding of transcriptional proteins and thus inhibiting gene expression 
(Tahiliani et al, 2009). 
DNA methylation is considered more of a stable/long-term epigenetic 
modification that is often linked to long-term silencing of genes and genes 
involved with imprinting (Wu and Zhang, 2010).  DNA methylation is very 
important for development, and different cells will have methylation at different 
points in the genome depending on either the cell type, the tissue type, or the 
developmental stage (Tan and Shi, 2012).  Abnormal methylation patterns have 
been discovered in tumor cell DNA, specifically showing an increase in 5mC at 
the promoters of tumor suppressor genes, causing inhibition of expression of 
those genes leading to tumor formation (Cimmino et al, 2011). DNA methylation 
is carried out by enzymes called DNA methyltransferases, or DNMTs.  There are 
two methods of DNA methylation which use different DNMTs; either “de novo” 
methylation or “maintenance” methylation. 
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De novo DNA methylation occurs in order to establish the pattern of 
methylation within the genome.  It is carried out by DNMT3A and DNMT3B, 
which will place a methyl group in the 5 position of cytosine to create 5mc (Wu 
and Zhang, 2010).  Introduction of 5mC is often associated with inhibition of gene 
expression (Branco et al, 2012).  This de novo methylation of the DNA will occur 
early in embryonic development, during the blastocyst stage, and then the 5mC 
will be maintained through a process known as maintenance methylation (Wu 
and Zhang, 2010). 
Maintenance methylation occurs in order to maintain this epigenetic 
marker within the genome of daughter cells after replication.  DNMT1 is the 
enzyme responsible for maintenance methylation and it is recruited specifically to 
hemi-methylated DNA, or DNA where one strand is methylated and one strand is 
not (i.e. newly replicated DNA) (Sharif et al, 2007).  It has been shown that 
deletion of these DNMT enzymes causes embryonic lethality and mutations in 
them cause serious developmental impairments, suggesting their necessity in the 
development process (Wu and Zhang, 2011).   
 
DNA DEMETHYLATION 
  It was once believed and widely accepted that DNA methylation was a 
stable and irreversible modification within the epigenome, but it has recently 
been seen that methylation marks within the DNA can go through many changes 
during several points after fertilization, including during the establishment of 
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primordial germ cells (PGCs) (Branco et al, 2012).  Relatively high levels of 5-
hydroxymethylcytosine, or 5hmC, in embryonic stem cells are further evidence 
that 5mC is being modified and therefore DNA is being demethylated (Cimmino 
et al, 2011).  5hmC is the product of the oxidation of 5mC by the ten-eleven 
translocation (TET) family of proteins.  These TET proteins use -ketoglutarate 
as a co-substrate to oxidize 5mC into 5hmC and then can further oxidize this 
modified cytosine into 5-formylcytosine (5fC) and/or 5-carboxylcytosine (5caC) 
(Tan and Shi, 2012).   
  It is widely accepted that a passive demethylation pathway exists in order 
to remove the methyl groups from DNA.  This pathway occurs when DNMT1, the 
maintenance DNA methyl transferase enzyme, is either missing or unable to act 
on the DNA within the cell (Wu and Zhang, 2010).  One possible mechanism for 
this inhibition is via the oxidation of 5mC to 5hmC.  DNMT1 is not capable of 
recognizing 5hmC and therefore no longer sees this DNA as hemi-methylated.  
As a result, it will no longer bind and methylate the newly replicated strand of 
DNA. (Cimmino et al, 2011).  Over several cell cycles, this will lead to the 
complete loss of 5mC at this point in the genome, as newly replicated DNA will 
not be methylated and therefore this epigenetic information will be lost in the new 
generation of cells. 
In mammals it has been seen that immediately following fertilization, the 
genome of the paternal pronucleus is globally demethylated, and again within 
primordial germ cells, there is a rapid loss of DNA methylation within one cell 
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cycle, suggesting that an active pathway to DNA demethylation must also exist 
(Wu and Zhang, 2010; Cimmino et al, 2011).  Further evidence that an active 
DNA demethylation pathway must exist is the change in methylation patterns 
within the genome in cells that do not replicate, including neuronal cells 
(Cimmino et al, 2011).  There are several proposed pathways for this active 
demethylation of the DNA. 
One possibility is the existence of an enzyme that directly demethylates 
5mC into unmodified C within the genome.  However, there has been a lot of 
controversy surrounding the enzymes that could possibly be performing this task.  
One protein, Methylated DNA Binding Domain-containing Protein (MBD2) has 
been suggested to directly demethylate 5mC producing methanol and unmodified 
cytosine (Guo et al, 2011).  However, this protein has been intensely scrutinized 
and no other labs were able to duplicate/verify these results (Wu and Zhang, 
2010).   
Other research points to the possible involvement of enzymes called DNA 
glycosylases, since these enzymes perform a similar function in plants.  This 
hypothesis suggests that the protein Thymine DNA Glycosylase (TDG) is 
responsible for directly excising the entire 5mC from the genome, creating an 
apurinic site that is then the target of base excision repair mechanisms that will 
put an unmodified cytosine in its place (Wu and Zhang, 2010).  While TDG has 
been shown to possess 5mC glycosylase activity, this activity is very weak 
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compared to the TDG glycosylase activity at other bases and therefore is 
probably not responsible for genome-wide demethylation (Guo, 2011). 
Another possible mechanism which seems more promising is the 
combination of a deamination pathway with a base excision repair pathway.  The 
proposed mechanism involves an enzyme called Activation Induced Deaminase 
(AID) deaminating cytosine to produce uracil, and then that uracil, which is 
incorrectly paired with a guanine, will be replaced with a cytosine by TDG (Wu 
and Zhang, 2010).  A major flaw in this pathway is that AID has only been seen 
to deaminate 5mC in single stranded DNA, not in double stranded DNA (Wu and 
Zhang, 2010).  However, AID has been shown to deaminate 5hmC to 5hmU, 
which can then go through a base excision repair pathway similar to the one 
described earlier (Cimmino et al, 2011).  In fact there are enzymes that have an 
especially high affinity for 5hmU:G mismatch that are likely involved in this base 
excision repair pathway, including Selective Monofunctional Uracil-DNA 
Glycosylase 1 (SMUG1) and TDG (Branco et al, 2012).   
There is a good amount of research supporting this deamination/base 
excision repair pathway as a mechanism of active DNA demethylation.  One 
study has shown that overexpression of AID leads to a decrease in 5hmC levels, 
and overexpression of both AID and TET together leads to an overall decrease in 
5mC levels (Cimmino et al, 2011).   Recent studies have shown that the enzyme 
TDG is actually capable of excising 5hmU, 5fC or 5caC from DNA, but it is not 
able to remove 5hmC or 5mC (Hashimoto et al, 2012).  This research provides 
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more evidence for the deamination pathway and argues against the direct 
excision pathway suggested above.  Yet another study has shown that AID 
knockout leads to increased methylation of PGCs, suggesting that active 
demethylation is at least partially blocked.  However, there is still some 
demethylation occurring in these PGCs, suggesting alternative pathways that are 
also involved in active demethylation of DNA (Guo et al, 2011). 
 It is also important to note that the TET proteins can further oxidize 5hmC 
into 5fC or 5caC.  These compounds may also play a role in active DNA 
demethylation.  It has been shown that TDG can recognize and remove 5fC and 
5caC, replacing them with an unmodified cytosine via base excision repair (Tan 
and Shi, 2012).  It has also been suggested that 5caC could simply be 
decarboxylated, leaving behind an unmodified cytosine (Cimmino et al, 2011).  
While this pathway is certainly feasible, TET proteins are not capable of carrying 
out this reaction and thus a separate decarboxylase would have to exist in order 
to complete the demethylation to an unmodified cytosine (Tan and Shi, 2012). 
 
5hmC AND THE DIFFERENT TET FAMILY ENZYMES  
It is clear that 5hmC is involved in several of the potential DNA 
demethylation pathways being studied.  For instance, in the deamination 
pathway described above, 5hmC is a much better substrate for AID than 5mC is.  
It is also possible that 5hmC is acting as its own epigenetic modification, 
interrupting binding of transcription factors that normally recognize 5mC but are 
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unable to recognize 5hmC (Wu and Zhang, 2010).  It also seems clear that 
5hmC is involved in the passive DNA demethylation pathway, as DNMT1 cannot 
recognize 5hmC and therefore will not replicate the methylation mark in daughter 
cells and thus 5mC will eventually be lost (Cimmino et al, 2011).   
New research has shown that the TET proteins, which convert 5mC to 
5hmC, may be recruited specifically to euchromatin and not to heterochromatin 
(Kubiura et al, 2012).  The mechanism of the specificity of this recruitment 
remains to be uncovered, but it seems that it may be based on different points of 
methylation within histone proteins.  It is possible that this isolation of the TET 
enzymes to euchromatin may serve to produce 5hmC and thus protect the DNA 
from DNMT activity, blocking methylation and therefore also stopping the 
inhibition of gene expression that often accompanies 5mC (Kubiura et al, 2012; 
Taliliani et al, 2009).  Research is still being done to work out if 5hmC is its own 
epigenetic entity or if it is simply an intermediate step in the process of 
demethylating genomic DNA (Branco et al, 2012).   
Some studies have shown that 5mC is first oxidized to 5hmC by TET 
enzymes, and then 5hmC levels gradually decline (Wu and Zhang, 2011).  These 
studies would suggest that 5hmC is serving as an intermediate in demethylation 
of 5mC back to unmodified cytosine.  Along with these studies, evidence that 
TET enzymes can further oxidize 5hmC into 5fC and 5caC seems to suggest that 
5hmC is just one step in the demethylation process (Cimmino et al, 2011).  More 
research is still required to look at the importance of 5fC and 5caC in active DNA 
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demethylation, including the possibility of a decarboxylase to convert 5caC into 
unmodified cytosine (Tan and Shi, 2012). 
New research, however, suggests that 5hmC may in fact be an important 
epigenetic marker that is essential for neuronal function.  A recent study shows 
that accumulation of 5hmC within neuronal cells does not seem to be associated 
with DNA demethylation, and therefore is serving its own unique epigenetic 
purpose (Hahn et al, 2013).  In the same study it was also shown that increased 
5hmC levels in gene bodies seems to activate genes that are crucial for the 
differentiation of neurons. 
It seems likely that 5hmC has unique functions in stem cells and 
specialized cells including neurons (Cimmino et al, 2011).  While studies show 
differing results on whether TET proteins are required to maintain the self-
renewing capabilities of embryonic stem cells, they are required for cell lineage 
differentiation (Koh et al, 2011).  This suggests that active DNA demethylation, 
facilitated by the TET family enzymes, is an important and necessary step in 
development and cell lineage differentiation. 
 The TET family of enzymes includes TET1, TET2 and TET3, all of which 
possess a C-terminal catalytic domain which has 2-oxoglutarate and iron(II)-
dependent dioxygenase activity that can use alpha-ketoglutarate to oxidize 5mC 
into 5hmC (Tan and Shi, 2012).  However, the different TET proteins have been 
seen to function in different cell types and during different stages of development. 
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 TET1 is found in abundance in embryonic stem cells, and it seems to have 
the ability to either repress or activate its many target genes (Wu and Zhang, 
2011).  It has been shown that TET1 binds with high affinity to CpG dinucleotides 
and tends to be concentrated around transcription start sites (TSSs) and 
promoter regions.  It is believed that TET1 is preventing hypermethylation at 
these sites and therefore promoting transcription of these genes, increasing their 
expression levels (Branco et al, 2012).  Nanog, a transcription factor involved in 
pluripotency of cells, is an example of a gene that is activated by the presence of 
TET1 (Wu and Zhang, 2011).  However, studies have also shown that some 
genes are down regulated by the presence of TET1, and these genes are often 
involved in lineage specificity (Wu and Zhang, 2011).  This data taken together 
indicates that TET1 is responsible for maintaining pluripotency of cells while 
repressing cell lineage differentiation.   
 While TET2 is also found with fairly high abundance in embryonic stem 
cells, much of the research involving TET2 is related to its role in hematopoietic 
cells and leukemia.  TET2 mutations and associated DNA hypermethylation are 
seen with great frequency in patients suffering from human myeloid malignancies 
(Wu and Zhang, 2010).  While the extent of the effect of TET2 on myeloid 
malignancies needs to be studied further, it has been shown that TET2 deletion 
will cause an increase in the size of the stem cell and progenitor cell pools within 
the hematopoietic system, as well as an increase in the self-renewal capabilities 
of these cells (Wu and Zhang, 2011).  Certainly these TET2 mutations need to be 
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studied further, but it has been shown that TET2 deletion is sufficient to begin a 
myeloid transformation and therefore TET2 serves as tumor suppressor 
(Cimmino et al, 2011). 
 TET3 is the only one of the TET proteins which is found in very high levels 
within zygotes and oocytes and then quickly decreases after the two-cell stage 
(Wu and Zhang, 2011).Thus, TET3 must be the enzyme responsible for the 
genome wide demethylation of the paternal pronucleus upon fertilization (Tan 
and Shi, 2012).  TET3 may not be linked to carcinomas, but it is essential for 
proper embryonic development, and it’s deletion from either PGCs or a growing 
oocyte will cause severe developmental impairment (Wu and Zhang, 2011).  
TET3 also seems to be involved with adult neurogenesis, as TET3 expression is 
increased in the cortex during neuronal differentiation (Hahn et al, 2013).  
Neurons have been shown to have the highest levels of 5hmC out of all cell 
types within mice, including mouse embryonic stem cells, implying that TET 
proteins are very important for proper neuronal function (Wu and Zhang, 2011). 
 
TET ENZYMES AND THEIR CONNECTION TO OGT ACTIVITY 
 Very recently, multiple studies have looked at the association of TET 
proteins with O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT), a 
protein that is responsible for glycosylation of serine and threonine residues 
(Vella et al, 2013).  OGT has been linked to many different metabolic pathways 
and has been shown to have a connection to diabetes.  Increased OGT 
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expression has been associated with increased insulin resistance and therefore 
is also linked to increased development of type II diabetes mellitus (Vella et al, 
2013).  Different research groups have observed links between OGT and TET 
proteins.  The studies do have conflicting results in terms of which TET protein is 
binding to OGT, as one group found TET1 and TET2 to be binding and another 
group found TET2 and TET3 to be associated with OGT, but it is possible that 
the reason for these conflicting results is linked to different methodologies used 
to study the protein associations (Balasubramani and Rao, 2013).  These studies 
all seem to suggest that TET-OGT association has some important 
consequences on gene expression. 
 OGT is required for embryonic development and several targets of its 
enzymatic activity have been discovered, including several histone proteins 
(Vella et al, 2013).  Recent studies looking at the association of TET proteins to 
OGT has provided evidence that TET proteins (either TET1 or TET2 or possibly 
both) are responsible for recruiting OGT to the chromatin, therefore allowing it to 
glycosylate the histone proteins (specifically H2B) and thus affect gene 
transcription (Chen et al, 2013; Vella et al, 2013).  Since OGT transfers a glucose 
onto a hydroxyl group during its enzymatic mechanism, one group looked to see 
if OGT was capable of glycosylating 5hmC; it was not capable of glycosylating 
5hmC and did not seem to have an effect on the production of 5hmC by TET 
(TET2 in this case) (Chen et al, 2013).   
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 These studies have shown that the TET family of proteins is one of many 
that are capable of affecting OGT activity.  Since OGT has been linked to 
diabetes, as discussed earlier, it is of interest to understand if the TET family of 
proteins and their product (5hmC) may also be connected to this disease.  As 
discussed previously, the TET proteins have been linked to many forms of 
cancer and developmental diseases, but little research has been done to look at 
the possible connection between TET proteins and diabetes. 
  
KIAA1310 AND THE NSL COMPLEX 
    Much of the research presented within this paper is related to a protein 
called KIAA1310, which is also known as KANSL3 or simply NSL3 and is 
orthologous to RCD1 in plants (”KANSL3 Gene”, 2012).  KIAA1310 has been 
seen to associate with many different protein complexes, but its actual function or 
enzymatic activity is still unknown (Raja et al, 2010).  Our research group has 
recently found that KIAA1310 co-precipitates with TET2 and with TET3, making 
this a protein of interest.  
 KIAA1310, also referred to as NSL3, has been seen to associate with a 
complex called MOF, which is the catalytic subunit of a histone acetyl transferase 
found in both humans and drosophila (Cai et al, 2010).  MOF has been seen to 
associate with both the Non-Specific Lethal (NSL) and Male-Specific Lethal 
(MSL) complexes within drosophila, which seem to be evolutionarily conserved in 
humans (Mendjen et al, 2006).  MOF can acetylate different substrates 
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depending on which of these complexes it is associated with.  When human MOF 
is bound with the MSL complex, it specifically acetylates H4K16 (Lysine 16 on 
histone protein H4), whereas it will acetylate H4K5, H4K8 and H4K16 when it is 
bound to the NSL complex (Cai et al, 2010).  These histone modifications will 
have various epigenetic effects, as discussed at the beginning of this 
introduction. 
 It has been seen that the NSL complex is an important transcriptional 
regulator, recruiting the pre-initiation complex to begin transcription, especially 
within housekeeping genes (Lam et al, 2012).  A different study showed that a 
decrease in MOF causes a decrease in the ability of the NSL complex to recruit 
these proteins and therefore affects gene transcription (Raja et al, 2010).  
Therefore, it is clear that the NSL complex and its acetyltransferase subunit, 
MOF, are very important for regulation of gene transcription.  Understanding the 
role of KIAA1310 within these complexes, as well as the association with TET 
proteins that has recently been observed, may provide significant insight into the 
field of epigenetics and lead to medical and pharmacological breakthroughs in 
the future. 
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SPECIFIC AIMS 
 
 
One goal of the research presented in this paper is to continue studying 
the uncharacterized protein KIAA1310 and look at its connection to the TET 
family of proteins, specifically TET2 and TET3.  A cell line that had been 
transfected with a pOZ-FH-N vector containing the gene for the protein of interest 
as well as FLAG and HA tags was used.  These cells were cultured over time 
until a large enough quantity was obtained for use of tandem affinity purification 
(TAP) to purify the KIAA1310 protein complex.  This purified sample was 
subjected to MS/MS analysis in order to gain insight into the other proteins that 
are found in the cells connected to KIAA1310.   
 A second aim, not connected to the study of KIAA1310, was to look at 
5hmC levels among diabetic patients to study any connection.  This research 
was inspired by the previous research mentioned earlier that shows a connection 
between TET proteins and OGT, an enzyme that has been connected to the 
development of type II diabetes mellitus.  In order to look at the 5hmC levels, we 
performed a dot-blot assay using anti-5hmC antibodies and DNA samples from 
patients with and without diabetes.  The results were quantified in order to 
establish if there is in fact a connection between 5hmC levels and diabetes. 
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MATERIALS AND METHODS 
 
 
CULTURING CELLS EXPRESSING KIAA1310 
Members of our research group had previously created a stable cell line 
expressing a pOZ-FH-KIAA1310 plasmid construct.  These cells were placed in 
10 cm culture dishes with media containing DMEM, 10% FBS and PQ/L.  The 
cells were incubated at 37oC and media was changed regularly.  In order to 
prevent overgrowth and death, cells were trypsinized and split into additional 10 
cm culture dishes as well as 25 cm culture flasks when necessary (every 48-72 
hours).    
 Eventually, these cells were moved into a suspension culture in order to 
grow a larger volume of cells.  The cells were trypsinized and then added to a 1L 
autoclaved culture flask with 500 mL of culture media.  The flasks were incubated 
at 37oC with a stir bar/stir plate in order to provide constant agitation and prevent 
cell adherence to the sides of the flask.  Cell counts were taken daily and fresh 
media was added when necessary.  After about 2 weeks, when the suspension 
culture volume totaled 16L, the cells were harvested in order to perform tandem 
affinity purification. 
 
IMMUNOFLUORESCENT STAINING 
 A portion of the cells cultured were cultured directly onto glass coverslips 
in six-well plates in order to perform IF staining.  These cells were washed two 
times with PBS and then fixed in 4% paraformaldehyde for 15 minutes.  They 
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were then washed in PBS again and then incubated in PBS with 0.5% TritonX-
100 for 30 minutes in order to permeabilize the cells.  Next the cells were 
incubated for 30 minutes in 2N HCl and then neutralized with 100mM Tris-HCL 
for 10 minutes. 
 The cells were washed three times with PBS-T, at 5 minutes per wash.  
The cells were then blocked in a solution of 0.05%PBS-T with 1% BSA overnight 
in a 4oC cold room.  The next morning, the coverslips were incubated with 150L 
each of primary antibody solution for 2 hours at room temperature.  The primary 
antibody solution contained mouse anti-flag mAb and Rabbit anti-5hmC 
polyclonal Ab, both of which were diluted at 1:1000 in 1%BSA containing PBS.    
 After incubation with the primary antibodies, the coverslips were once 
again washed three times for five minutes each with PBS-T.  Following the third 
wash, 1.5 mL of secondary antibody was added to each coverslip.  The 
secondary antibody contained Goat-Anti-Rabbit 594 and Goat-Anti-Mouse 488 
antibodies, both of which were diluted at a 1:4000 ratio in 1%BSA in PBS-T.  The 
coverslips were incubated in this secondary antibody solution overnight in the 
4oC cold room. 
 The next morning, after removing the secondary antibody, the coverslips 
were washed with PBS-T containing DAPI at a 1:1000 dilution for 10 minutes at 
room temperature.  They were then washed twice for five minutes each with 
PBS-T.  The coverslips were then rinsed with PBS, rinsed with ddH20, and then 
mounted face down onto glass carry slides using 25L fluoromount-G mounting 
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media.  These slides were stored at -20oC in complete darkness until ready for 
image capturing.  A Nikon Eclipse 90i microscope was used with a Photometrics 
CoolSnap EZ camera and Nikon image capturing software in order to obtain 
fluorescent images of these cells.   
 
TANDEM AFFINITY PURIFICATION 
 All of the media from the suspension culture flasks was evenly distributed 
among autoclaved 1L spin bottles.  These bottles were centrifuged at 3000 rpm 
and 4oC for 10 minutes.  The supernatant was discarded and the cell pellets 
were rinsed with ice cold PBS.  The cells were then combined and centrifuged 
again for 4 minutes at 3000 rpm and 4oC.  The supernatant was poured off and 
again the cells were washed with ice cold PBS.  This PBS with cells suspended 
in it was then aliquoted into 50mL tubes, and these tubes were centrifuged at 
3000 rpm and 4oC for another 4 minutes.  The PBS was poured off and 
hypotonic buffer was added.  The cells were incubated for 20 minutes on ice in 
this hypotonic buffer, with occasional inversion. 
 After 20 minutes, these tubes were centrifuged at 4oC for 10 minutes, this 
time at a reduced speed of 2500 rpm.  The speed was reduced because the cells 
are swollen from the hypotonic incubation and therefore more delicate than 
before.  The supernatant was poured off and saved at -80oC.  The pellet was 
loosened from the side of the tube with a gentle flick, and more hypotonic buffer 
was added, using a volume equal to the volume of the cell pellet. 
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 The cells in hypotonic buffer were then transferred to a 40mL Dounce 
Homogenizer and dounced 25 times.  This portion of the procedure was carried 
out in the 4oC cold room.  After douncing, the sample was transferred to 50 mL 
tubes and centrifuged at 4oC and 3000 rpm for 15 minutes.  The lipid layer 
floating at the surface was removed with a pipette tip, and the supernatant was 
aliquoted and saved as Crude S-100 at -80oC.  
 The volume of the nuclear pellet was measured and half of this volume of 
low salt buffer was added to the pellet.  This mixture was then placed into an 
autoclaved beaker with a stir bar.  Using the same volume as for  the low salt 
buffer, high salt buffer was titrated drop wise into this beaker and then the whole 
mixture was incubated at 4oC while spinning for 30 minutes.  This sample was 
then carefully transferred into microcentrifuge tubes and centrifuged for 10 
minutes at 3000 rpm and 4oC.  The lipid layer was once again removed and the 
supernatant was transferred into autoclaved microcentrifuge tubes.  The 
chromatin pellet was saved at -80oC.  The supernatant was then centrifuged at 
15,000 rpm and 4oC for 40 minutes. 
 32 mm SpectroPor prewet MWCO 8000KDa dialysis tubing was cut and 
prepped by folding one end and clipping with dialysis clip and then briefly rinsing 
in dialysis buffer.  After the high speed spin mentioned previously was finished, 
the lipids were removed and the supernatant was transferred to a new tube.  This 
supernatant was then transferred to the dialysis bag and the open end was 
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folded and clipped.  The dialysis bag was placed in dialysis buffer and dialyzed 
overnight in the 4oC cold room with a stir bar providing constant agitation. 
 The following morning, the sample was transferred from the dialysis bag 
into microcentrifuge tubes that had already been rinsed with cold ddH20.  The 
sample was centrifuged for 30 minutes at 15,000 rpm and 4oC.  While the sample 
was spinning, the magnetic beads for the next step of the procedure were 
prepared. 
 The beads were removed from storage at -20oC and suspended in PBS (1 
mL of PBS for every 100L of beads).  They were then centrifuged at room 
temperature and 3000 rpm for 3 minutes.  Supernatant was removed by vacuum, 
and 500 L of 0.1M glycine (pH 2.7) was added.  The beads and glycine were 
mixed, centrifuged at 3000 rpm for 3 minutes (at room temperature) and then the 
supernatant was again removed by vacuum.  Ice cold 1M Tris (pH 7.9) was 
added to the beads, mixed, and incubated for 10 minutes on ice.  The beads 
were then centrifuged at 3000 rpm and room temperature for 3 minutes. 
 After centrifugation, 1 mL was transferred to a new tube, centrifuged at 
15,000 rpm and 4oC for 10 minutes, aliquoted and saved as “Flg In” at -80oC.  
The rest of the sample was used to suspend the beads and then they were 
incubated at 4oC overnight with constant rotation.   
 The next morning, the beads were centrifuged at 1200 rpm and 4oC for 5 
minutes.  The supernatant was aliquoted and saved as “Flag FT” at -80oC.  The 
beads were washed three times with wash buffer and then transferred in 1 mL of 
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wash buffer to a small column.  The tube was rinsed with 1mL of wash buffer and 
this was also transferred to the column, in order to ensure no beads were 
wasted.  The column was emptied simply by gravity flow and then spun dry at 
1000 rpm and 4oC for 5 minutes.  Elution buffer was then added to the column 
and allowed to flow through the column.  The column was again spun at 1000 
rpm and 4oC for 5 minutes, and the eluate was saved as “FLAG E1” at -80oC.  
Glycine was then used for the final elution, which was performed the same as the 
other elutions (flow through column with gravity, spun at 1000 rpm and 4oC for 5 
minutes) and then neutralized with Tris (pH 8.0).  This final eluate was saved as 
FLAG E3 at -80oC. 
 
WESTERN BLOT 
 In order to ensure that the elution products from the TAP procedure 
contain the protein of interest, KIAA1310, a western blot was run and analyzed.  
In order to prepare the samples, 40L of the sample and 20 l of 4XSDS loading 
dye were placed into a microcentrifuge tube.  After mixing, the solutions were 
boiled for 10 min to inactivate the protein, mixed and briefly spun.  An aliquot (30 
L) of each sample was loaded onto a 10% acrylamide gel and electrophoresed 
in 1X running buffer for 1 hour at 200V.  The protein was then transferred 
overnight onto a nitrocellulose membrane (Whatman, 0.2m pore size) in the 4oC 
cold room at 30A. 
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 The next day, the membrane was stained for 3 minutes in Ponceau S dye 
and then rinsed with ddH2O.  It was then blocked in a solution of 5% milk in PBS-
T with two washes of 15 minutes each.  The membrane was then incubated for 2 
hours in the primary antibody solution, a dilution of 1:1000 of antibody in the 
PBS-T milk.  After this 2 hour incubation, the membrane was washed three times 
at 10 minutes each in PBS-T milk.  The membrane was then incubated for 1 hour 
in secondary antibody (a 1:3000 dilution).  After this incubation with the 
secondary antibody, the membrane was once again washed three times at 10 
minutes each time in PBS-T milk.  The membrane was then rinsed with PBS-T 
and then with ddH20 and was then developed using PerkinElmer Western 
Lightening ECL.  The exposure times used were 90 seconds, 2 minutes, and 10 
minutes. 
 
CONCENTRATING AND ANALYZING KIAA1310 
 For further study, the protein sample was concentrated using a TCA 
(trichloroacetic acid) precipitation technique.  The E1 and E3 elution products 
were combined and NP-40 was added to a final concentration of 0.5%.  100% 
TCA was added to a final concentration of 20%.  The sample was then incubated 
for 15 minutes on ice with the TCA in order to pull down the protein bound to it.  
The sample was then spun for 15 min at 14,000 rpm and 4oC.  The supernatant 
was carefully removed and then 100 L of acetone was added to the sample.  
The sample was mixed until the acetone dissolved completely and then was 
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incubated for 5 minutes on ice.  The sample was then spun down for 10 minutes 
at 14,000 rpm and 4oC, and the supernatant was removed.  The sample was left 
in the open air at room temperature for 5 minutes and then spun under rotary 
evaporation for 5 minutes in order to remove any remaining acetone. 
 The final, concentrated, protein pellet was then packaged and shipped to 
the epigenetics laboratories at the Fudan University in Shanghai, China, where it 
underwent MS/MS analysis.  The results from the MS/MS were entered into the 
STRING program for further study (Jansen et al, 2009). 
 
DETECTING 5hmC USING ELISA KIT 
 In order to study the second aim listed above, patient DNA samples were 
subjected to the Quest 5-hmC DNA ELISA Kit (Zymo Research).  This was a 
blind study, meaning some of the DNA came from diabetic patients and some 
came from control patients and all of the samples were provided a random 
sample number in order to prevent bias in the procedure.  The goal of this 
procedure was to measure the 5hmC levels in the DNA of each of these patients, 
so that later the 5hmC levels of diabetic and non-diabetic patient DNA could be 
compared. 
 The first step was to coat the wells by diluting the anti-5hmC polyclonal 
antibody to a final concentration of 1ng/L in the provided coating buffer.  100mL 
of this solution was added to each well and incubated for one hour at room 
temperature, with the wells covered to prevent any evaporation.  The wells were 
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then blocked in order to prepare for the addition of the DNA samples.  1X ELISA 
buffer was prepared by diluting the provided 10X ELISA buffer with ddH20.  The 
anti-5hmC antibody was removed from the wells and each well was washed 
three times with 1X ELISA buffer, using 200L each time.  A one hour, room 
temperature incubation with 200L of 1X ELISA buffer occurred next, with the 
wells again covered to prevent evaporation. 
 While the wells were being blocked, the DNA samples were denatured to 
prepare them for binding.  400ng of DNA from each sample was diluted in 15L 
of water and denatured in a thermocycler for 10 minutes at 98oC, after which they 
were immediately spun down and put on ice to prevent reannealing.  100L of 1X 
ELISA buffer was then added to each sample and the samples were then added 
to the prepared wells.  The DNA samples were incubated in the anti-5hmC 
antibody coated wells for one hour at room temperature, covered with foil to 
prevent evaporation. 
 After one hour of incubation time, the wells were washed three times with 
1X ELISA buffer, using 200L per wash.  The secondary antibody, an anti-DNA 
HRP antibody, was prepared in a 1:100 dilution using 1X ELISA buffer and 
100L of this secondary antibody dilution was added to each well.  The wells 
were covered and incubated with the anti-DNA HRP antibody for 30 minutes at 
room temperature.   
 After this 30 minute incubation, the wells were once again washed three 
times with 200mL of 1X ELISA buffer.  100L of the provided 1X developer was 
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added to each well and the wells were left at room temperature until color 
development was visible (about 25 minutes).  The wells were then placed in a 
plate reader to measure the absorbance at a wavelength of 415 nm. 
 The ELISA kit used came with a set of five control samples, each with a 
different set percentage of 5hmC in the DNA.  Unfortunately, upon development 
it was clear from these controls that the experiment had not provided accurate or 
reliable data.  At this point, several different troubleshooting methods were 
attempted.  The first step was to have Zymo Research send a fresh batch of 
antibody, as the kit had been stored for a few months.  In the next attempt at this 
protocol, 400ng of DNA instead of 200ng were used for each sample.  During this 
attempt, the DNA was allowed to incubate in the coated wells overnight at 4oC 
rather than for one hour at room temperature, in order to provide more ample 
time for DNA binding.  Finally, the developer was allowed to incubate for 60 
minutes.  This extended period of time led to overdevelopment, so the wells were 
washed with 1X ELISA buffer, fresh developer was added and the wells were 
read every 5 minutes for a 45 minute period. 
 Despite all of the attempts made to troubleshoot this protocol, the results 
were still deemed inaccurate based on the absorbance readings of the five 
supplied control samples.  It was then decided that perhaps the problem was in 
the design behind this ELISA kit itself, and a different experimental procedure in 
order to look at these DNA samples and measure the 5hmC levels. 
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ANTI-5hmC DOT BLOT 
 In order to accomplish the second aim, a dot blot assay was used to 
determine 5hmC levels in the DNA of diabetic patients.  DNA samples from 78 
patients were used.  Some of these patients were diabetic and some were not, in 
order to prevent any bias in the experiment.  The goal was to determine if a 
difference in 5hmC levels could be detected between the diabetic and non-
diabetic patients.  If successful, this would suggest a possible difference in TET 
protein activity between patients with diabetes and patients without diabetes. 
 A nitrucellulose membrane (Whatman, 0.2m pore size) was incubated in 
ddH20 for 20 minutes and then in 6X SSC buffer for 20 minutes.  Meanwhile, 125 
ng of each patient DNA sample in 30L of TE buffer was mixed with 20 L of a 
solution containing 1M NaOH and 25mM EDTA.  This mixture was denatured for 
10 minutes at 95oC in a thermocycler.  After this denaturation the DNA was 
immediately spun down and put on ice and 50L of ice cold 2.0M ammonium 
acetate was added to each sample.  This mixture sat on ice for 10 minutes, was 
spun down and then returned to ice until the membrane was ready.  After 
incubation, the membrane was placed in a Bio-Rad dot blot apparatus, 400L of 
TE buffer was added to each well to rehydrate the membrane, and vacuum was 
applied.  The samples were then applied to the wells and 100L of TE buffer was 
placed in any well that was not being used for a DNA sample.  The vacuum was 
again applied only until all liquid had gone through the apparatus and caution 
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was taken not to over vacuum the membrane.  The membrane was then washed 
with 400L of 2X SSC buffer per well and vacuum was once again applied.  The 
apparatus was disassembled; the membrane was briefly rinsed in 2X SSC and 
then placed in a 37oC incubator to dry.  Once dry, the membrane was placed 
under UV light for 20 minutes to cross-link the DNA to the membrane.  After this 
cross-linking, the membrane was blocked for one hour in 5% milk in PBS-T. 
 After this incubation, the membrane was rinsed with PBS-T and then the 
primary antibody was added.  A rabbit-anti-5hmC antibody was diluted at a ratio 
of 1:10,000 in 5%milk PBS-T solution.  The primary antibody incubation lasted for 
one hour at room temperature.  The membrane was then rinsed with ddH2O and 
then washed three times for 10 minutes each in  PBS-T.  The membrane was 
then incubated for 1 hour at room temperature in the secondary antibody, a 
1:4000 dilution of HRP-conjugated goat-anti-rabbit antibody in 5% milk PBS-T.  
After this incubation the membrane was again rinsed with ddH2O and then 
washed three times for 10 minutes each in PBS-T. 
 The membrane was then rinsed with ddH2O and was developed using 
PerkinElmer Western Lightening ELC and the image was developed with an 
exposure time of 1 second.  The image was then scanned into the computer 
using Adobe Photoshop and the relative density of each dot (and therefore the 
relative quantity of 5hmC in each sample) was measured using BioRad Quantity 
One Analysis Software.   
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RESULTS 
 
STABLE CELL LINE ESTABLISHED EXPRESSING KIAA1310 
 In order to ensure that the protein of interest, KIAA1310, was being 
expressed in the cells being cultured, an immunofluorescent staining assay was 
performed.  The cells were incubated with both an anti-FLAG antibody and an 
anti-5hmC antibody.  The results show that KIAA1310 is indeed being expressed 
in these cells (Fig 1A and 1D).  This figure also demonstrates that 5hmC is 
present in these cells, indicating that TET proteins are functioning (Fig 1B and 
1E).  From these results it cannot be conclusively determined if there is an 
increase or decrease in the 5hmC level of these cells, meaning it is not apparent 
whether increased KIAA1310 expression is having an effect on TET proteins in 
the cell either by activating or repressing their activity. 
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Figure 1: Immunofluorescence to verify KIAA1310 
expression in cell line.  A,D: Fluorescence shows 
presence of anti-FLAG antibody (green), indicating that 
KIAA1310 is present in the cells.  B,E: Anti-5hmC 
staining shows the presence of 5hmC in the cells, thus 
indicating that the TET proteins are functioning.  C,D: 
DAPI nucleic acid stain to confirm that the staining 
assay worked properly. 
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TAP ELUTION PRODUCT CONTAINS KIAA1310 
  
After all of the cells in the suspension culture were harvested and they 
underwent the TAP (Tandem Affinity Purification) assay protocol, a western blot 
was performed in order to ensure the elution products contained the protein of 
interest, KIAA1310.  The results of the western blot clearly show that KIAA1310 
is present in both E1 and E3 (Fig 2).  These results show that the TAP protocol 
worked as expected and that the protein of interest had been isolated from the 
cells into the samples and could therefore be concentrated and studied further. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Western blot of the samples from the different 
stages of TAP assay.  The membrane was exposed for 10 
minutes to produce this image.  The red arrow in the image 
indicates where the size of the KIAA1310 protein.  The 
bands at this protein size in FLAG E1 and FLAG E3 show 
that the KIAA1310 protein is present in these two samples.  
Not surprisingly, bands for this protein are also seen from 
samples of the flow through, the crude nuclear extracts and 
the final nuclear extract. 
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MS/MS ANALYSIS OF KIAA1310 PROTEIN COMPLEX 
 
 Upon completion of the TAP assay, the concentrated elution products 
were sent to the epigenetics lab at Fudan University in Shanghai, China, where 
they underwent proteomic MS/MS analysis.  A vast amount of different proteins 
were found to interact with KIAA1310 (Fig 3).  Much more analysis needs to be 
done in order to understand how all of these proteins are interacting with 
KIAA1310.  It is important to note that many metabolic pathway proteins and 
many transcription factors were found in complex with KIAA1310.  These 
associations are evidence that the protein KIAA1310 is probably involved in both 
transcriptional regulation of genes as well as regulation of different metabolic 
pathways.   
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Figure 3: Interactome of KIAA1310 based on proteomic MS/MS 
analysis.  This is a representation of all of the proteins found associated 
with the purified and concentrated KIAA1310 that was sent out for MS/MS 
analysis.  This interactome was created using the STRING database 
(Jansen et al, 2009). 
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QUEST ANTI 5hmC ELISA KIT IS NOT CAPABLE OF ACCURATELY 
PORTRAYING 5hmC LEVELS IN DNA 
  
An ELISA kit was obtained in order to study the relative levels of 5hmC in 
DNA samples from 78 patients.  7 of these samples did not contain a high 
enough concentration of DNA to be used, and therefore 71 of these samples 
were measured using the kit.  The kit, which was obtained from Zymo Research 
Inc, also contained 5 separate control DNA samples, each with a different known 
percentage of 5hmC.  DNA was denatured and the ssDNA was added to wells 
coated with anti-5hmC antibodies in order to selectively bind DNA containing 
5hmC.  The secondary antibody was an anti-DNA HRP antibody, to detect the 
amount of bound DNA from each sample and thus to detect the relative 5hmC 
level of each DNA sample. 
 The purpose of the 5 control samples was to create a standard curve in 
order to quantitate the percent of 5hmC in the patient DNA samples.  
Unfortunately, when the absorbance levels of the 5 controls were graphed 
against the given 5hmC percentages, the resulting graph did not look at all like 
the expected standard curve, indicating that the procedure had not worked 
properly (Fig 4).  
It is important to note that the trendline of our data points has an R2 value 
of only 0.6498 (Fig 4).  The standard curve given in the Zymo Research Inc 
protocol for this ELISA kit has an R2 value of 0.9874.  This indicates that a linear 
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graph is a very poor fit for our data and therefore the relationship between 
absorbance and %5hmC that was expected is not being seen.  Also, since the 
results from both the initial experiment and the troubleshooting experiment yield 
the same equation and R2 value for their regression lines, it suggests that the 
difference between our results and the expected results did not stem from either 
too low of a DNA concentration or too low of an incubation period between the 
primary antibody and the ssDNA.  
 
 
 
 
 
 
 
Since the control samples of DNA provided by the Zymo Research Inc, the 
makers of the ELISA Kit, were unable to yield an accurate standard curve, it 
seems that the subsequent results from our patient DNA samples would also be 
Figure 4: Standard curves graphing known %5hmC of control 
samples versus their absorbance reading at 415 nm.  For both graphs, 
the absorbance reading was taken at the peak of color development of the 
assay, about 45 minutes. A: The first attempt at using the ELISA kit, 
protocol was done exactly as directed by Zymo Research Inc. B: This 
graph is a product of our troubleshooting attempt.  The DNA concentration 
was increased so the total amount of DNA was 400 ng instead of 200 ng 
and the DNA was incubated with the anti-5hmC antibody overnight at 4oC 
instead of for 1 hour at room temperature. 
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inaccurate and unreliable.  This meant a different method must be used to look at 
the relative 5hmC levels in the patient DNA samples, as this ELISA assay was 
clearly insufficient. 
 
ANTI-5hmC DOT BLOT ASSAY SHOWS RELATIVE DIFFERENCES IN 5hmC 
LEVELS IN DNA BETWEEN DIABETIC AND NON-DIABETIC PATIENTS 
    
 After the failure of the anti-5hmC ELISA kit to produce reliable results, an 
anti-5hmC dot blot procedure was performed on the same samples in order to 
study any existing correlation between 5hmC levels and diabetic status.  The 
density of each dot was measured in order to observe any relative differences in 
the 5hmC levels of the DNA in each sample.  It was determined that on average, 
the diabetic patients’ DNA contained a lower level of 5hmC than the control 
patients (Table 1).  This data agrees with previous research done in our lab 
looking at a small subset of these patient samples.   
Further analysis of this data was done comparing the relative 5hmC level 
with the HbA1c level of diabetic patients.  HbA1c is a measure of the average 
blood glucose level over the previous 3 months.  It is a reliable way to measure 
how well a patient is managing their diabetes (A.D.A.M. 2012).  A higher HbA1c 
level indicates less control over the diabetes than a lower HbA1c level would.  
The HbA1c levels of the diabetic patients were compared to the density 
measured for their sample in the dot blot protocol, representing their relative  
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Controls Density 
 
Diabetic Density 
ggr005 8636.15   ggr001 8684.02 
ggr006 8230.35   ggr003 8009.43 
ggr007 10357.91   ggr004 7753.88 
ggr012 7120.55   ggr008 10195.72 
ggr015 9631.64   ggr009 5159.63 
ggr017 5751.82   ggr011 7640.66 
ggr019 7276.65   ggr013 5935.29 
ggr020 7710.57   ggr014 8032.45 
ggr021 5647.82   ggr016 6241.97 
ggr023 7732.82   ggr018 6238.61 
ggr024 7754.10   ggr022 5615.80 
ggr026 7742.27   ggr025 7953.96 
ggr030 8751.55   ggr027 5570.64 
ggr032 8911.67   ggr028 5464.14 
ggr033 9047.37   ggr029 7152.35 
ggr035 9746.72   ggr031 7421.15 
ggr038 12104.53   ggr034 8641.69 
ggr044 8551.80   ggr036 10035.59 
ggr046 7115.66   ggr037 6590.23 
ggr048 6965.52   ggr042 6125.38 
ggr050 9034.56   ggr045 6472.23 
ggr052 9703.40   ggr047 8470.81 
ggr055 10618.56   ggr049 9581.49 
ggr056 11995.21   ggr051 7401.50 
ggr058 5662.91   ggr054 8301.68 
ggr060 9760.07   ggr057 7287.19 
ggr061 9368.39   ggr059 7884.70 
ggr063 8585.56   ggr062 8505.23 
ggr066 9675.18   ggr064 8585.67 
      ggr065 7554.68 
average 8592.804       
      average 7483.59 
Table 1: Comparison of dot blot density 
between diabetic and control patients.  
This table compares the density of the dot 
produced by each sample during the dot 
blot assay.  This density is correlated to the 
%5hmC in the DNA sample.  As can be 
seen, the average density and therefore 
the average %5hmC is higher in the control 
patients than in the diabetic patients. 
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5hmC level.  The results led to a conclusion that there is somewhat of a negative 
correlation between these two factors (Fig 5).  That is, a patient with a higher 
5hmC level will have a lower HbA1c level and vice versa.  This would again 
suggest that 5hmC and the TET enzymes responsible for its production may be 
involved with the pathology of diabetes. 
 
 
 
 
 
 
 
 
 
Figure 5: Relationship between 5hmC level in DNA and HbA1c level in 
blood of diabetic patients.  The graph shows that there is a negative 
correlation between density of the sample in the dot blot and HbA1c level in 
the patient.  Since the density is a direct measure of the relative amount of 
5hmC in the patients DNA, this suggests that 5hmC level and HbA1c level 
are negatively correlated.  That is, a high 5hmC level corresponds to a 
lower HbA1c level. 
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DISCUSSION 
 
 In order to accomplish the first portion of the specific aims listed earlier in 
this paper, cells expressing a KIAA1310 containing plasmid were cultured and 
harvested.  This protein was then purified and concentrated before undergoing 
proteomic MS/MS analysis.  The results of this MS/MS analysis are quite 
extensive and will require much more investigation in the future. 
 Many of the proteins that were found associated with KIAA1310 are 
involved in different metabolic pathways.  This suggests a possible role of 
KIAA1310 in metabolic processes.  More research is required to see how 
KIAA1310 is associating with these proteins and what function it is serving in 
these complexes. 
 KIAA1310 was also found to associate with many different transcription 
factors.  This is in agreement with the observations discussed in the introduction 
that suggest a role of the NSL complex and MOF complex in regulation of gene 
transcription/expression.  Understanding which transcription factors are 
associating with KIAA1310 and how these associations are being formed may 
help elucidate how MOF and NSL are executing control over gene transcription. 
 Metabolic proteins and transcription factors are not the only proteins found 
coupled with KIAA1310 after MS/MS analysis.  As can be seen in figure 3, an 
extensive group of proteins with a wide variety of functions was found bound to 
this protein.  Unfortunately, time constraints prevented the in-depth analysis of 
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this interactome that is necessary to fully understand the many associations 
made by KIAA1310, but this is surely an area for continued research.  
 More exploration remains to be done into the role of KIAA1310 itself within 
the TET complex.  One direction this research could take in the future would be 
to look at the biochemical role of KIAA1310.  Conducting an enzymatic activity 
assay could provide insight into what affect KIAA1310 may have on the proteins 
it interacts with or on the DNA.  As stated earlier, the existence of a 5caC 
decarboxylase remains to be seen, so it could be possible that KIAA1310 is 
playing this role.  There are many other roles that KIAA1310 could be playing 
within the DNA demethylation pathway, which is why this type of research is 
necessary in the future. 
 Further down the road, understanding the role KIAA1310 is playing 
biologically, or within the whole organism, may be an important and necessary 
step.  Conducting studies with knockdown or knockout mice to understand what 
phenotypic changes occur when KIAA1310 is absent may serve to understand 
what role KIAA1310 plays when it is present.  Studies such as this may help to 
determine if KIAA1310 is involved with development and disease. 
 In order to accomplish the second aim set out earlier in this paper, DNA 
samples were obtained from both diabetic and control patients in order to 
compare the levels of 5hmC present in their DNA.  After attempting to use the 
Zymo Research Inc Quest 5-hmC DNA ELISA Kit unsuccessfully despite 
troubleshooting attempts, it was concluded that the problem was with the design 
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of the kit itself.  The logic behind this assay is to use wells that are coated with 
anti-5hmC antibody in order to pull down any DNA that contains 5hmC.  These 
wells are then washed with anti-DNA HRP antibody and developed in order to 
quantitate the relative amount of DNA that is bound to the wells and therefore to 
quantitate the relative amount of 5hmC in each DNA sample.  However, there is 
a major flaw in the logic of this protocol.  
 Since the secondary antibody is an anti-DNA antibody, the signal 
produced can vary based on how much DNA is in the well.  That is, if the DNA 
fragments are of variable length, the secondary antibody will bind to a variable 
degree regardless of the 5hmC content.  In other words, a longer DNA fragment 
with only one 5hmC residue in it may show a stronger signal upon development 
than a shorter DNA fragment which contains multiple 5-hmC residues.  This flaw 
in logic is most likely the reason that the ELISA kit did not give accurate 
absorption readings for the control samples.  Due to the unreliable results of the 
ELISA kit, an anti-5hmC dot blot assay was performed to observe any possible 
correlation between diabetic status of patients and the level of 5hmC in their 
DNA. 
The results of this anti-5hmC dot blot assay show that the average density 
measured was lower for diabetic patients than for control patients.  Since the 
density is a direct measurement of the 5hmC level in the DNA, our results show 
that, on average, diabetic patients have less 5hmC in their DNA than control 
patients.  This difference in 5hmC levels does suggest that there is a connection 
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between 5hmC, and therefore the TET family proteins, and the pathology of 
diabetes.  More research must be done to validate these results and to further 
understand what role the TET proteins might be playing in the pathology of the 
disease. 
If this experiment is repeated and these results can be validated, it could 
mean a great deal for the understanding of epigenetic medicine and diabetes.  If 
a decreased 5hmC level truly is correlated to an increased incidence of diabetes, 
this could provide an opportunity for a novel mechanism to treat this disease.  It 
may also lead to the ability to detect diabetes earlier and therefore control and 
manage the disease better.  And, since it was seen that lower 5hmC corresponds 
to higher HbA1c, or less control of the disease, there is potential that 5hmC could 
be helpful in the regulation of blood glucose in diabetic patients.  All of these 
possibilities require much more examination into this connection. 
Although this dot-blot assay was much more successful than the ELISA kit 
that was first tried, there are still a few limitations of the procedure.  The biggest 
problem is that it only allowed for 60 samples to be tested on one membrane.  
This meant that in a large cohort, it would not be possible to compare more than 
60 samples.  One possible solution to this would be to develop multiple 
membranes with different samples loaded in the same concentrations on them.  
In order to ensure uniformity, the membranes would have to be incubated in the 
same antibody and they would have to be developed together in order to ensure 
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the same film exposure time across membranes.  This approach will be used in 
the future to validate these results and to compare more samples. 
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CONCLUSION 
 
 In summary, this research has made strides in understanding the different 
proteins involved with the TET enzymes in the DNA demethylation pathway as 
well as the possible involvement of these TET proteins in different diseases such 
as diabetes.  The protein KIAA1310 was successfully isolated, purified and 
concentrated before undergoing proteomic MS/Ms analysis.  It was found to be 
associated with many metabolic pathway proteins and transcription factors, 
indicating that it may be involved in a variety of important mechanisms within the 
cell.  More research is necessary in order to elucidate the biochemical and 
biological roles of this protein.   
 This study also discovered an association between decreased 5hmC 
levels and diabetic status.  This indicates that decreased TET or at least 
decreased TET activity probably also corresponds to diabetes.  This association 
needs to be confirmed and more studies need to be run to elucidate exactly what 
effect the TET proteins and their product, 5hmC, are having in relation to HbA1c, 
blood glucose, and dibetes.  It will be important in the future to continue studying 
this association, as more information could lead to new epigenetic treatments 
that may be more efficient than the current treatments available. 
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